RESULTS:
Standard sonography was performed in 40,346 pregnancies at 18-21 6/7 weeks, and 11,792 (29%) had at least 1 follow-up exam. Major abnormalities were confirmed in 398 infants (1%), with 251 (63%) detected on the initial sonogram, and 43 (11%) and 8 (2%) detected on the first and second follow-up exams, respectively. Figure 1 depicts anomaly detection during initial and subsequent sonograms. Detection of residual anomalies on follow up sonograms was not significantly different from detection on the initial screening sonogram -63% on the initial exam, 58% for first follow-up, and 53% for second follow-up, P¼0.56. However, because fewer undetected anomalies remained, a larger number of follow-up examinations were required per anomalous fetus detected, P<0.001. Number of follow-up examinations to detect each additional anomalous fetus was not affected by gestational age at which follow-up sonography was performed, P¼0.92 (Table 1 ). Survival to hospital discharge was significantly lower for fetuses with anomalies detected on initial (88%) or first follow-up exams (91%) than for fetuses with anomalies undetected until delivery (94/95, 99%), both P<0.02. CONCLUSION: Follow-up sonography resulted in detection of nearly 60% of fetal anomalies that had not been identified during the initial screening sonogram in a non-referred population. However, more follow-up sonograms were required to detect each additional anomalous fetus. th %ile at enrollment) were divided into two groups: those meeting ISUOG criteria (FGR-I; n¼25) selecting a more pathologic cohort, and FGR controls (FGR-C; n¼20) not meeting strict criteria. The final ultrasound exam prior to delivery (w35 weeks) was used to obtain biometry, EFW, and 3D FLV acquisition. 3D FLV was completed by estimating the total thigh volume (TTV) along the femur using a 5-slice technique, as well as subcutaneous fat (SQ) and lean mass (LM; bone + muscle) volume assessments. RESULTS: Compared to the FGR-C group, the FGR-I group delivered at a similar GA, but with a significantly lower birth weight. Compared to the FGR-C group, the FGR-I group showed significant reductions in TTV, SQ, and LM (Table 1) . CONCLUSION: The significant difference in birth weights between the FGR-C and FGR-I groups who delivered at a similar gestational age validates our two comparison groups. The significant difference in TTV, SQ, and LM found between the two groups suggests that the FGR group meeting ISUOG criteria (FGR-I) may represent a more pathologic phenotype of FGR. Use of the FLV when evaluating FGR pregnancies may improve the ability to distinguish between normal and pathologic FGR. 
